Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
about
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityPolymorphic repeat in AIB1 does not alter breast cancer riskVariants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association studyDecreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: preliminary data from the GOOS study.Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast.Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women.Anti-oestrogenic prevention of breast cancer--the make or break point.Aromatase activity and bone loss in men.Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Pharmacogenomics and breast cancer.Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females.Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight.A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancerGenetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women.Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese menHaplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.Preventive oncology in the postmenopausal woman.Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women.Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.Polymorphic variation in CYP19 and the risk of breast cancer.
P2860
Q24679438-D9797053-D186-41A8-8766-5DCC62AAAC54Q24791382-FF742A09-D8BB-41CA-9153-C35E783C9CDBQ24796616-B7763A7C-3BE6-48D7-AB68-DB92BDD6D30CQ31119548-0C44A597-ED8C-46DE-A949-A0A46A90969DQ33584258-349DF72C-F173-4927-8AE0-E8785A895832Q33844619-6675E42A-8B6B-4724-A9BD-EDF61ACA823AQ34291721-83FBF347-F99A-4464-93E6-8136203CFFF5Q34386787-E56B00A2-8536-4B05-B74E-B15676B36721Q34667211-4CC787FE-4167-4541-B063-4B6AD79198F6Q34932305-DACC989A-CADA-4C82-BCA1-85810EF5D60CQ35101538-E60243A9-CAF5-44DC-92F0-1C441ED91A3DQ35593300-6A93CA30-96AF-4FEA-8CD5-D5D7CC69082BQ35610513-98A2709E-E615-43E5-87A8-A19CB326B43AQ35648546-36DDDA6B-A6E7-4BF4-975D-A70878F37928Q36620855-EAC0B1B6-B55E-4DF0-B762-3B113EA4DC59Q36641661-1F59B742-925A-4822-B05F-646F8BBCB0DAQ36646582-DA04F29F-03B6-48F3-B128-BE42E18576E7Q37036706-40562B9A-AA7A-40B5-B613-50EB3BFA6A46Q37036843-BB959081-3537-4348-8014-629084D8633CQ37078017-385FA9B9-0D43-42EC-8FF0-96187A7B6B6FQ37384632-0CEBC787-87B4-483C-BE9D-184E78CE1204Q37608402-A51AC956-3FDA-424F-9624-9158A93A2893Q37669267-0F23DAAD-D55D-4572-BF01-BD66DA503DA3Q43747296-401194A0-7AFC-48FC-910A-F269E19A89D8Q44183331-FA8D2639-C878-4CB1-8465-C0353ABE10FFQ44819882-8DBC3ADF-BD81-4CA9-8CE9-00A48ADF8402Q45197592-854D3298-2D05-4372-8B76-B31CD42E9A42Q53401950-CC6F86AA-6C8B-4863-BA25-2C8CF4721FC8
P2860
Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@ast
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@en
type
label
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@ast
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@en
prefLabel
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@ast
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@en
P2860
P356
P1476
Constitutional genetic variati ...... (Cyp19) and breast cancer risk
@en
P2093
K H Buetow
N Siegelmann-Danieli
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690071
P407
P577
1999-02-01T00:00:00Z